UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048946
Receipt number R000055768
Scientific Title Oral training demonstration for kindergarten children
Date of disclosure of the study information 2022/09/17
Last modified on 2023/03/27 13:50:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Oral training demonstration for kindergarten children

Acronym

Oral training demonstration for kindergarten children

Scientific Title

Oral training demonstration for kindergarten children

Scientific Title:Acronym

Oral training demonstration for kindergarten children

Region

Japan


Condition

Condition

Healthy child

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Oral training demonstration for kindergarten children

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

*Chewing ability evaluation
*Upper lip capture test
*Lip aspect ratio
*Tongue and lip movement
*Blowback test
*Fusen gum inflation
*Whistling test
*Oral questionnaire

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Food

Interventions/Control_1

Test food

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit

6 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Those who are able to consume the test food
(2) Those who are able to perform the work under the guidance of their teachers and guardians.
(3) Those who are not allergic to any of the foods (egg bolo and test food)
(4) Those who have received a full explanation of the purpose and content of the test, have the ability to consent, understand it well, and voluntarily volunteer to participate, and have a parent or guardian who can consent to their participation in the test in writing.

Key exclusion criteria

(1) Those with symptoms that may affect the intake of the test food.
(2) Those who may develop allergies related to the study.
(3) Those who are judged by the study representative to be inappropriate to participate in this study.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Kazuto
Middle name
Last name Okabayashi

Organization

Lotte Co., Ltd.

Division name

Central Laboratory, Kamukoto Research Department

Zip code

336-8601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0744

Email

okabayashi_kazuto@lotte.co.jp


Public contact

Name of contact person

1st name Kenji
Middle name
Last name Oosawa

Organization

Lotte Co., Ltd.

Division name

Central Laboratory, Kamukoto Research Department

Zip code

336-8601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0744

Homepage URL


Email

oosawa_kenji@lotte.co.jp


Sponsor or person

Institute

Lotte Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Lotte Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Yamaguchi Dental Association

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic

Address

6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

Tel

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

56

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 08 Month 24 Day

Date of IRB

2022 Year 09 Month 08 Day

Anticipated trial start date

2022 Year 10 Month 03 Day

Last follow-up date

2022 Year 12 Month 14 Day

Date of closure to data entry

2022 Year 12 Month 14 Day

Date trial data considered complete

2022 Year 12 Month 28 Day

Date analysis concluded

2023 Year 03 Month 21 Day


Other

Other related information



Management information

Registered date

2022 Year 09 Month 16 Day

Last modified on

2023 Year 03 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055768


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name